DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes
Key Points
• DHODH inhibition synergizes with DNA-demethylating agents in the treatment of MDS.
• DHODH inhibition enhances the incorporation of decitabine into DNA in MDS cells.